
Corporate
Minerva Neurosciences Details Phase 3 Roluperidone Trial at LifeSci KOL Event — First Patient Expected Q2 2026
5h ago
You're signed outSign in or to get full access.
Browse quarterly earnings call transcripts for Minerva Neurosciences Inc.
No earnings call transcripts available for NERV.